Great company..
Ceo has already started and sold one biopharm..
Will always keep the shorts and longs guessing..
Is it for sale or isn’t it?
Haha.. good luck to longs!!!!!
Ceo has already started and sold one biopharm..
Will always keep the shorts and longs guessing..
Is it for sale or isn’t it?
Haha.. good luck to longs!!!!!
Recent ANVS News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:15:21 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2026 08:12:15 PM
- Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants • GlobeNewswire Inc. • 05/20/2026 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/19/2026 09:25:43 PM
- Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants • GlobeNewswire Inc. • 05/19/2026 08:06:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:00:58 PM
- Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/15/2026 11:30:00 AM
- Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026 • GlobeNewswire Inc. • 05/07/2026 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 09:02:41 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:55:10 PM
- Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio • GlobeNewswire Inc. • 04/28/2026 12:00:00 PM
- Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission • GlobeNewswire Inc. • 04/10/2026 12:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/09/2026 09:09:42 PM
- Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants • GlobeNewswire Inc. • 04/09/2026 12:30:00 PM
- The Credibility Filter Wall Street Uses to Sort Biotech Winners • GlobeNewswire Inc. • 04/08/2026 01:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 08:39:11 PM
- Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections • GlobeNewswire Inc. • 04/02/2026 11:30:00 AM
- Annovis Publishes Historical Review of Buntanetap in The Scientist • GlobeNewswire Inc. • 03/31/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 09:19:03 PM
- NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 09:06:04 PM
- Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results • GlobeNewswire Inc. • 03/16/2026 11:30:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/13/2026 09:15:44 PM
